Antitrust may not be drugmakers’ top policy concern

Ben Remaly

27 January 2020

Antitrust may not be drugmakers’ top policy concern

Credit: Shutterstock/James Andrews1

As pharmaceutical companies lobby against bipartisan efforts to curb prescription drug prices, there may be room for competition-related bills to be signed into law.